This inventor holds 7 USPTO granted patents and 1 published patent application and 6 EPO patents. Top assignees: Bristol-Myers Squibb Compnay, Viiv Healthcare UK (No.5) Limited. Active years: 2016-2021.
Location History:
- Karnataka, IN (2016)
- Bengaluru, IN (2016 - 2021)
Company Filing History:
5 out of 3,736 
2 out of 45 Years Active: 2016-2021
Title: The Innovative Contributions of Selvakumar Kumaravel
Introduction
Selvakumar Kumaravel is a prominent inventor based in Bengaluru, India. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of treatments for human immunodeficiency virus (HIV) infection. With a total of seven patents to his name, Kumaravel's work has had a substantial impact on medical research and treatment options.
Latest Patents
Kumaravel's latest patents focus on inhibitors of human immunodeficiency virus replication. These patents include compounds of Formula I, which encompass pharmaceutically acceptable salts and compositions aimed at treating HIV infection. His innovative approach in this area showcases his commitment to advancing healthcare solutions.
Career Highlights
Throughout his career, Kumaravel has worked with notable companies such as Bristol-Myers Squibb Company and ViiV Healthcare UK (No. 5) Limited. His experience in these esteemed organizations has allowed him to hone his skills and contribute to groundbreaking research in the pharmaceutical industry.
Collaborations
Kumaravel has collaborated with several professionals in his field, including Upender Velaparthi and Mark D. Wittman. These partnerships have facilitated the exchange of ideas and fostered innovation in their shared pursuits.
Conclusion
Selvakumar Kumaravel's contributions to the field of HIV treatment through his patents and collaborations highlight his role as a key innovator in pharmaceutical sciences. His work continues to inspire advancements in medical research and treatment methodologies.